Latest Graves' disease Stories
Companies Include Silarus Therapeutics Developing Treatments for Anemia and Iron Overload Disorders; and Thyritope Biosciences Developing Treatments for Graves' Orbitopathy SAN DIEGO,
DIEPENBEEK, Belgium, June 19, 2014 /PRNewswire/ -- Initiates Preclinical Development of Peptide Therapy Apitope, the drug discovery and development company
Millions of people worldwide suffer with infertility and recurrent miscarriage and in thousands of unexplained cases, hypothyroidism may be the underlying cause.
An overactive thyroid gland, or hyperthyroidism, may increase the risk of hospitalization for heart and blood-vessel disease even after surgery to remove the gland
Even moderate thyroid dysfunction during early pregnancy significantly increases the risk of serious complications, underscoring the need for universal screening in the first trimester.
Children of mothers screened and treated for reduced thyroid function during pregnancy show no signs of improved IQ compared to women who receive no treatment, new research has uncovered.
A recent study completed by researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) demonstrates that BMC conducts a high rate of thyroid function testing in pregnant women.